– Start-up Company Developing Safer, Less Expensive Gastrostomy Method – CoapTech Receives Maryland Innovative Initiative Award to Further Advance the Technology BALTIMORE, Nov. 29, 2016 /PRNewswire/ — University of Maryland (UM) Ventures and CoapTech, LLC, announced today that the University of Maryland, Baltimore (UMB) has granted CoapTech exclusive licensing rights for the commercial development of […]
GlycoMimetics joins leading patient advocacy groups, researchers, clinicians, policymakers, industry, and foundations in a collective effort to improve sickle cell disease (SCD) care, early diagnosis, treatment, and research both in the United States and globally. The newly formed Sickle Cell Disease Coalition’s first order of business is an international call to action to change the […]
Dr. Iyer discusses WellDoc’s IDEA framework in this short video.
ROCKVILLE, Md., Oct. 24, 2016 /PRNewswire/ — BioHealth Innovation, Inc. (BHI) announced today that the Maryland Economic Development Corporation (MEDCO), who is the agent for Montgomery County, has selected BHI to manage the Germantown Innovation Center (GIC) located within the Pinkney Innovation Complex for Science and Technology at Montgomery College (PIC MC). The Germantown Innovation […]
Gaithersburg biotech startup Vtesse Inc. — a company with a goal to commercialize National Institutes of Health rare disease drug candidates — secured $17 million in additional Series A funding. Read more via the Washington Business Journal
Anand Iyer, Chief Strategy Officer of WellDoc, joins Pat Salber (@docweighsin) to talk about the incredible journey of WellDoc, the first digital health company to get FDA clearance and a billing code so they can be reimbursed by insurance companies.
Three common disorders that are on the rise worldwide—attention deficit hyperactivity disorder (ADHD), memory loss, and cardiovascular disease—may be more manageable thanks to a growing area of research and development in “medical foods.” And VAYA Pharma, one of the newest BioPark tenants, is developing medical foods that may hold the key to better management of […]
Ten clinical sites now enrolling patients in the United States, the United Kingdom, Spain, France and Germany Vtesse, Inc. announced that the dose-finding portion of the company’s global, pivotal Phase 2b/3 clinical trial for its lead investigational product, VTS-270, for treatment of Niemann-Pick Type C1 Disease (NPC) is now complete, and a dose level for further […]
At its first Demo Day on March 23, Relevant Health, a health technology startup accelerator in the Washington, DC metro area, hosted a group of more than 150 investors, industry leaders and top technology company representatives to experience first-hand the progress of the accelerator’s seven health tech startups. Coming from Bethesda, Rockville, Washington, DC, Baltimore, […]